Combination of hdac inhibitor and anti-pd-1 antibody for treatment of cancer
作者： Robert Goodenow , Peter Ordentlich
DOI:
关键词:
摘要: Described herein are methods for the treatment of cancer in a subject. In particular, provided non small cell lung and melanoma with combination entinostat an anti-PD-1 or anti-PD-L1 antibody.
lens.org参考文章(42)
Kathleen M Mahoney, Michael B Atkins, Prognostic and predictive markers for the new immunotherapies. Oncology. ,vol. 3, pp. 39- 48 ,(2014)
Leisha A Emens, Ashley Cimino-Mathews, Jeremy B Foote, Immune Targeting in Breast Cancer Oncology. ,vol. 29, pp. 375- 385 ,(2015)
Mark D. Jaffe, Michael L. Gautsch, Jeffrey P. Gambino, Robert L. Barry, Bradley A. Orner, Kevin N. Ogg, Phillip F. Chapman, Segmented guard ring structures with electrically insulated gap structures and design structures thereof ,(2013)
Francesca De Felice, Claudia Marchetti, Innocenza Palaia, Daniela Musio, Ludovico Muzii, Vincenzo Tombolini, Pierluigi Benedetti Panici, Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors. Clinical & Developmental Immunology. ,vol. 2015, pp. 191832- 191832 ,(2015) , 10.1155/2015/191832
Hui Zhang, Novel suicidal lsd1 inhibitors targeting sox2-expressing cancer cells ,(2014)
Alfonso R. Gennaro, Remington: The Science and Practice of Pharmacy ,(2003)
David M. Woods, Andressa L. Sodre, Eva Sahakian, John Powers, Maritza Lienlaf-Moreno, Patricio Perez-Villarroel, Alejandro Villagra, Javier Pinilla-Ibarz, Eduardo Sotomayor, Abstract 4090: Inhibition of class I histone deacetylases promotes robust and durable enhancement of PDL1 expression in melanoma: Rationale for combination therapy Cancer Research. ,vol. 74, pp. 4090- 4090 ,(2014) , 10.1158/1538-7445.AM2014-4090
Mutsuko Yamamoto-Ibusuki, Monica Arnedos, Fabrice André, Targeted therapies for ER+/HER2- metastatic breast cancer BMC Medicine. ,vol. 13, pp. 137- 137 ,(2015) , 10.1186/S12916-015-0369-5
John Wrangle, Wei Wang, Alexander Koch, Hariharan Easwaran, Helai P. Mohammad, Xiaoyu Pan, Frank Vendetti, Wim VanCriekinge, Timothy DeMeyer, Zhengzong Du, Princy Parsana, Kristen Rodgers, Ray-Whay Yen, Cynthia A. Zahnow, Janis M. Taube, Julie R. Brahmer, Scott S. Tykodi, Keith Easton, Richard D. Carvajal, Peter A. Jones, Peter W. Laird, Daniel J. Weisenberger, Salina Tsai, Rosalyn A. Juergens, Suzanne L. Topalian, Charles M. Rudin, Malcolm V. Brock, Drew Pardoll, Stephen B. Baylin, Alterations of immune response of non-small cell lung cancer with Azacytidine Oncotarget. ,vol. 4, pp. 2067- 2079 ,(2013) , 10.18632/ONCOTARGET.1542
Kei‐ichi Ozaki, Futaba Kishikawa, Masashi Tanaka, Toshiaki Sakamoto, Susumu Tanimura, Michiaki Kohno, None, Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross-resistance to a wide range of DNA-damaging drugs Cancer Science. ,vol. 99, pp. 376- 384 ,(2008) , 10.1111/J.1349-7006.2007.00669.X